Журнал "Почки" том 10, №3

Çì³ñò / Contents
²âàíîâ Ä.Ä.
Çäîðîâ’ÿ íåôðîíà — çàïîðóêà
ñòàá³ëüíîãî àðòåð³àëüíîãî òèñêó ................ 55
²âàíîâ Ä.Ä.
ßê ïîòåíö³þâàòè ä³þ ³íã³á³òîð³â
ðåí³í-àíã³îòåíçèí-àëüäîñòåðîíîâî¿
ñèñòåìè? ......................................................... 63
Ñó÷àñíà ôàðìàêîòåðàï³ÿ
Maria-Eliza Nedu, Mihaela Tertis, Cecilia Cristea,
Alexandru Valentin Georgescu
Ïîð³âíÿëüíå äîñë³äæåííÿ
âëàñòèâîñòåé ìåòèëåíîâîãî
ñèíüîãî ³ ïðîôëàâ³íó ³ ¿õ îïòèìàëüíèõ
òåðàïåâòè÷íèõ äîç ïðè çàñòîñóâàíí³
in vitro ³ in vivo .................................................. 71
Êóøí³ðåíêî Ñ.Â., ²âàíîâ Ä.Ä., Ðîòîâà Ñ.Î.,
Êóøí³ðåíêî Î.Â.
Ðåíîïðîòåêòîðí³ ìîæëèâîñò³ Lespedeza
capitata ó õâîðèõ íà õðîí³÷íó õâîðîáó
íèðîê ³ç öóêðîâèì ä³àáåòîì 2-ãî òèïó ......... 77
Ñàòüÿêóìàð ³äüÿøàíêàð,
Ïóòòàíàðàñà¿àõ Ìàõåøêóìàð,
Ïðàëõàä Ñ. Ïàòê³
Öèñòîí — êîìá³íîâàíèé ïðåïàðàò
ðîñëèííîãî ïîõîäæåííÿ — ³íã³áóº
àäãåç³þ óðîïàòîãåííî¿ E.ñoli
³ çíèæóº Í 2
Î 2
-³íäóêîâàíó òîêñè÷í³ñòü
NRK-52E êë³òèí ................................................. 85
Íàñòàíîâè
G. Bonkat (Chair), R. Bartoletti, F. Bruyère,
T. Cai, S.E. Geerlings, B. Köves, S. Schubert,
F. Wagenlehner
Óðîëîã³÷í³ ³íôåêö³¿ — 2021 ............................ 95
C. Radmayr (Chair), G. Bogaert, H.S. Dogan,
J.M. Nijman (Vice-chair), Y.F.H. Rawashdeh,
M.S. Silay, R. Stein, S. Tekgül
Äèòÿ÷à óðîëîã³ÿ .............................................. 99
Peter Nourse, Brett Cullis, Fredrick Finkelstein,
Alp Numanoglu, Bradley Warady,
Sampson Antwi, Mignon McCulloch
Íàñòàíîâè ISPD ùîäî ïåðèòîíåàëüíîãî
ä³àë³çó ïðè ãîñòðîìó óðàæåíí³ íèðîê:
îíîâëåííÿ 2020 ð. (ïåä³àòð³ÿ) .................... 102
D.D. Ivanov
Healthy nephrone — a guaranty
of stable blood pressure ................................. 55
D.D. Ivanov
How to potentialize the effect
of renin-angiotensin-aldosterone system
inhibitors? ......................................................... 63
Modern Pharmacotherapy
Maria-Eliza Nedu, Mihaela Tertis, Cecilia Cristea,
Alexandru Valentin Georgescu
Comparative Study Regarding
the Properties of Methylene Blue
and Proflavine and Their Optimal
Concentrations for In Vitro and In Vivo
Applications .................................................... 71
S.V. Kushnirenko, D.D. Ivanov, S.A. Rotova,
Î.V. Kushnirenko
Renoprotective opportunities of Lespedeza
capitata in patients with chronic kidney
disease and type 2 diabetes mellitus ........... 77
Satyakumar Vidyashankar,
Puttanarasaiah Maheshkumar,
Pralhad S. Patki
Cystone — an ayurvedic
polyherbal formulation inhibits
adherence of uropathogenic
E.coli and modulates H 2
O 2
-induced
toxicity in NRK-52E cells ................................... 85
Guidelines
G. Bonkat (Chair), R. Bartoletti, F. Bruyère,
T. Cai, S.E. Geerlings, B. Köves, S. Schubert,
F. Wagenlehner
Urological infections — 2021 .......................... 95
C. Radmayr (Chair), G. Bogaert, H.S. Dogan,
J.M. Nijman (Vice-chair), Y.F.H. Rawashdeh,
M.S. Silay, R. Stein, S. Tekgül
Pediatric urology ............................................. 99
Peter Nourse, Brett Cullis, Fredrick Finkelstein,
Alp Numanoglu, Bradley Warady,
Sampson Antwi, Mignon McCulloch
ISPD guidelines for peritoneal dialysis
in acute kidney injury: 2020 Update
(paediatrics) .................................................. 102
Òîì 10, ¹ 3, 2021
www.mif-ua.com, http://kidneys.zaslavsky.com.ua 5